Despite these concerns, our results revealed that CDA1 inhibited inflammation both in vivo and in vitro, suggesting that CDA1 may attenuate BLM-induced PF, partly by inhibiting the inflammation. The gene discussed is TSPYL2; the disease is pemphigus foliaceus.